Hisamitsu Pharmaceutical (United States)
- Research works
- 2 fractional, all time
- Citations
- 99 59.3 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
Not ranked overall: Hisamitsu Pharmaceutical (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Hisamitsu Pharmaceutical (United States) publish most on?
By volume: Botulinum Toxin and Related Neurological Disorders, Pain Management and Opioid Use, Pain Mechanisms and Treatments and Toxin Mechanisms and Immunotoxins.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Botulinum Toxin and Related Neurological Disorders Neurology 0 works
- 2 Pain Management and Opioid Use Anesthesiology and Pain Medicine 0 works
- 3 Pain Mechanisms and Treatments Physiology 0 works
- 4 Toxin Mechanisms and Immunotoxins Immunology 0 works
- 5 Transgenic Plants and Applications Biotechnology 0 works
- 6 DNA and Nucleic Acid Chemistry Molecular Biology 0 works
- 7 RNA Interference and Gene Delivery Molecular Biology 0 works
- 8 Microbial Inactivation Methods Biotechnology 0 works
- 9 Biopolymer Synthesis and Applications Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 19% is written across borders.
How has Hisamitsu Pharmaceutical (United States)'s research output changed?
Other research institutions in Florham Park
- BASF (United States)
- Zoetis (United States)
- Li Creative Technologies (United States)
- Shionogi (United States)
- Jacobs Levy Equity Management
- Cheshire Home
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.